Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict
null
Feb 19, 2026
finance.yahoo.com
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
undefined
Dec 2, 2025
finance.yahoo.com
Narcolepsy Market is Projected to Grow at a CAGR of 5.6% During the Forecast Period (2025-2034) Due to Increasing Disease Awareness, Improved Diagnosis, and Expanding Therapeutic Options | DelveInsight
#Product Stage #Customers
Sep 9, 2025
finance.yahoo.com
Strauss Group (TASE:STRS): Assessing Valuation After Mixed Q2 Earnings and Sales Growth
undefined
Sep 9, 2025
www.hotelmanagement-network.com
Westin Desaru Coast Resort partners with CAYIN Technology for digital signage
#Partners
Sep 9, 2025
finance.yahoo.com
Nikkiso Addresses Growing Ammonia-Handling Demand and Launches Next-Generation Pump at Gastech 2025
#Product Stage
Aug 30, 2022
www.marketscreener.com
Y-mAbs and Takeda Announces Marketing Authorization in Israel for DANYELZA® (naxitamab-gqgk) for Neuroblastoma | MarketScreener
#Customers
Apr 7, 2018
www.businesswire.com
Takeda Israel Awarded the Best Place to Work in Israel for 2018
Takeda is a global pharmaceutical company based in Japan. The company conducts research and development, manufacturing, and marketing of pharmaceutical products in various therapeutic areas, including oncology, gastroenterology, and central nervous system disorders. Takeda is also involved in the production of vaccines and has a significant presence in the global pharmaceutical market.
Takeda Pharmaceutical Company has a presence in Israel, mainly through its subsidiary Takeda Israel Ltd. The company conducts research and development activities in the country, focusing on areas such as oncology, neuroscience, and rare diseases. Takeda Israel also works with local partners and academic institutions to advance research and development in these areas. Additionally, Takeda Israel is involved in the commercialization and distribution of Takeda's products in Israel.
Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict
null
Feb 19, 2026
finance.yahoo.com
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
undefined
Dec 2, 2025
finance.yahoo.com
Narcolepsy Market is Projected to Grow at a CAGR of 5.6% During the Forecast Period (2025-2034) Due to Increasing Disease Awareness, Improved Diagnosis, and Expanding Therapeutic Options | DelveInsight
#Product Stage #Customers
Sep 9, 2025
finance.yahoo.com
Strauss Group (TASE:STRS): Assessing Valuation After Mixed Q2 Earnings and Sales Growth
undefined
Sep 9, 2025
www.hotelmanagement-network.com
Westin Desaru Coast Resort partners with CAYIN Technology for digital signage
#Partners
Sep 9, 2025
finance.yahoo.com
Nikkiso Addresses Growing Ammonia-Handling Demand and Launches Next-Generation Pump at Gastech 2025
#Product Stage
Aug 30, 2022
www.marketscreener.com
Y-mAbs and Takeda Announces Marketing Authorization in Israel for DANYELZA® (naxitamab-gqgk) for Neuroblastoma | MarketScreener
#Customers
Apr 7, 2018
www.businesswire.com
Takeda Israel Awarded the Best Place to Work in Israel for 2018